Why the study?
Does omitting a bonus-freeze improve procedure times without increasing atrial fibrillation recurrence in patients undergoing cryoballoon pulmonary vein isolation?
Does omitting a bonus-freeze improve procedure times without increasing atrial fibrillation recurrence in patients undergoing cryoballoon pulmonary vein isolation?
Answers are grounded in this paper and cite their sources.
Omitting bonus-freeze shortened procedures without higher recurrence in this cohort; leaves open randomized confirmation before practice change.
BACKGROUND: Second-generation cryoballoon based pulmonary vein isolation has demonstrated encouraging acute and mid-term clinical outcome. Customarily, a bonus-freeze is applied after successful pulmonary vein isolation. OBJECTIVE: To compare the long-term clinical outcome and safety profile of a bonus-freeze and a no bonus-freeze protocol. METHODS: A total of 120 consecutive patients with paroxysmal [95/120 (79 %)] or persistent atrial fibrillation [25/120 (21 %)] underwent CB2-based PVI. Freeze-cycle duration was 240 s. In the first 60 patients a bonus-freeze was applied after successful PVI (group 1), while in the following 60 patients the bonus-freeze was omitted (group 2). RESULTS: Procedure and fluoroscopy times were significantly shorter in group 2 [113.8 ± 32 vs 138.2 ± 29 min (p = 0.03) and 19.2 ± 6 vs 24.3 ± 8 min (p = 0.02)]. No differences in procedural complications were found. During a mean follow-up of 849 ± 74 (group 1) and 848 ± 101 days (group 2, p = 0.13) 69 % of patients (group 1) and 67 % of patients (group 2) remained in stable sinus rhythm without any differences between the groups (p = 0.69). CONCLUSIONS: Freedom from atrial fibrillation after second-generation cryoballoon based pulmonary vein isolation and a follow-up of >2 years is comparable when applying a bonus- and a no bonus-freeze protocol, while procedure and fluoroscopy times are significantly shorter when omitting the bonus-freeze. No differences in periprocedural complications were identified.
No takes yet. Share an insight, caveat, or question.
Heeger et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: